Nicholas Maestas
Director of Finance/CFO bij TEMPEST THERAPEUTICS, INC.
Vermogen: - $ op 31-03-2024
Profiel
Nicholas Maestas is currently the Secretary, Vice President-Finance & Strategy at Tempest Therapeutics, Inc. He previously worked as the Senior Director-Corporate Development & Operations at Immune Design Corp.
from 2014 to 2019 and as the Head-Financial Planning & Analysis at Alector, Inc. from 2019 to 2021.
Mr. Maestas completed his undergraduate degree at the University of California, Berkeley and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
03-01-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Nicholas Maestas
Bedrijven | Functie | Begin |
---|---|---|
TEMPEST THERAPEUTICS, INC. | Director of Finance/CFO | 12-07-2021 |
Eerdere bekende functies van Nicholas Maestas
Bedrijven | Functie | Einde |
---|---|---|
ALECTOR, INC. | Corporate Officer/Principal | 01-07-2021 |
IMMUNE DESIGN CORP | Corporate Officer/Principal | 01-07-2019 |
Opleiding van Nicholas Maestas
University of California, Berkeley | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ALECTOR, INC. | Health Technology |
TEMPEST THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |